APA (7th ed.) Citation

Mahon, F., Pfirrmann, M., Dulucq, S., Hochhaus, A., Panayiotidis, P., Almeida, A., . . . Saußele, S. (2024). European Stop Tyrosine Kinase Inhibitor trial (EURO-SKI) in chronic myeloid leukemia: Final analysis and novel prognostic factors for treatment-free remission. Journal of clinical oncology, 42(16), . https://doi.org/10.1200/JCO.23.01647

Chicago Style (17th ed.) Citation

Mahon, François-Xavier, et al. "European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-free Remission." Journal of Clinical Oncology 42, no. 16 (2024). https://doi.org/10.1200/JCO.23.01647.

MLA (9th ed.) Citation

Mahon, François-Xavier, et al. "European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-free Remission." Journal of Clinical Oncology, vol. 42, no. 16, 2024, https://doi.org/10.1200/JCO.23.01647.